Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-30

Clinical Trial Update: Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating alvimopan for constipation associated with prescription pain medications. The study was sponsored by Cubist Pharmaceuticals…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alvimopan (alvimopan)

Snippet

Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Constipation, Bowel Dysfunction | Phase 2 | Status: COMPLETED